Paul Frankenbach/LinkedIn
Sep 2, 2026, 17:22
Paul Frankenbach: New Insights into the Signaling Pathways of Antiphospholipid Antibodies at ISTH 2026
Paul Frankenbach, PhD Candidate at University Medical Center Mainz, shared a post on LinkedIn:
”I had the opportunity to present my research on the critical signaling pathways of different antiphospholipid antibodies at the International Society on Thrombosis and Haemostasis (ISTH) in Paris.
I am very grateful for the support from my supervisors Nadine Müller-Calleja and Wolfram Ruf, my co-authors and the DFG!
It was wonderful to connect with so many experts, exchange ideas, find new friends, and receive valuable feedback on my work.
Looking forward to continuing these discussions in the coming years!”
Stay updated with Hemostasis Today.
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union
-
Sep 2, 2026, 18:18Katie Gonzalez: Understanding the Hidden Risk of Inherited Thrombophilias
-
Sep 2, 2026, 18:14Beruni Narmada W: Rare Basal Vein of Rosenthal Thrombosis Presenting With Thalamic Haemorrhage
-
Sep 2, 2026, 18:03Omnia Ahmed: Effect of Hematocrit (HCT) on Coagulation Testing
-
Sep 2, 2026, 17:44John Thymis: Five E-Posters Presented at ESC Congress 2026 in Munich
-
Sep 2, 2026, 17:42Edward Lee Carter: In Antithrombotic Therapy, “More Protection” Can Become More Harm Surprisingly Quickly
-
Sep 2, 2026, 17:41Mohsin Raza: Why Is Anticoagulation Used During Hemodialysis?